47.JPG)
Neurovascular Devices or Interventional Neurology Market Size is valued at 3.29 Billion in 2024 and is predicted to reach 7.70 Billion by the year 2034 at a 9.0 % CAGR during the forecast period for 2025-2034.
Neurovascular conditions encompass intracranial aneurysms, ischemic stroke, subarachnoid hemorrhage, cavernous malformations, arteriovenous malformations, carotid disease, intracerebral hemorrhage, and moyamoya disease. Neurovascular devices treat a blood vessel or blood flow that impairs brain and nervous system function.
Multiple factors drive the growth of the neurovascular devices or interventional neurology market, including the increasing prevalence of neurovascular diseases, the development of new neurovascular devices, improved medical reimbursement policies, rising demand for safe and effective neurovascular devices, a well-established healthcare infrastructure, and an increase in research and development activities for neurovascular therapies. Besides this, growing patient demand for minimally invasive treatments results in the innovation and launch of neurovascular devices, which is likely to drive the growth of the neurovascular devices market. For instance, in August 2020, Stryker Corporation (US) launched the Surpass Evolve Flow Diverter and received U.S. FDA approval for the same. This diverter is the first 64-wire cobalt-chromium flow diverter in the U.S. designed to re-direct blood flow and promote aneurysm healing. However, the elevated cost of neurovascular devices and treatments may restrain the market’s growth.
The neurovascular devices or interventional neurology market is classified based on the products, end-users, and region. The products segment is categorized into aneurysm coiling & embolization devices (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting systems (carotid artery stents, embolic protection, balloon catheters), support devices (microcatheters and guidewires), and neurothrombectomy devices (clot retrievals, suction & aspiration, snares). By end-users, the market is segmented into hospitals & surgical centres, ambulatory care centres, and research laboratories & academic institutes. The hospitals & surgical centres segment is estimated to proliferate in the coming years due to the rising surgical operations and better reimbursement policies for hospital-based interventions. Geographically, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
North America is projected to witness lucrative growth in this market during the forecast period due to the well-developed healthcare facilities and rising prevalence of stroke & chronic diseases in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 3.29 Billion |
|
Revenue Forecast In 2034 |
USD 7.70 Billion |
|
Growth Rate CAGR |
CAGR of 9.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Products, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Johnson & Johnson (US), Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), Microport Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation (US), Balt (France), Perflow Medical (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (US), Lepu Medical (China), Cerus Endovascular (US), MicroVention, Inc. (US), Mizuho Medical (Japan), Peter Lazic GmBH (Germany), Spartan Micro (US), Emboflu (Switzerland), Straub Medical AG (Switzerland), AngioDynamics (US), Microbot Medical Inc. (US) and others. Companies Mentioned |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neurovascular Devices/Interventional Neurology Market Snapshot
Chapter 4. Global Neurovascular Devices/Interventional Neurology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Clinical Trial/Pipeline Analysis
4.8. COVID 19 Impact Analysis
Chapter 5. Neurovascular Devices/Interventional Neurology Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Aneurysm Coiling & Embolization Devices
5.2.1.1. Embolic Coils
5.2.1.1.1. Bare Detachable Coils
5.2.1.1.2. Coated Detachable Coils
5.2.1.2. Flow Diversion Devices
5.2.1.3. Liquid Embolic Agents
5.2.2. Cerebral Balloon Angioplasty & Stenting Systems
5.2.2.1. Carotid Artery Stents
5.2.2.2. Embolic Protection Devices
5.2.2.3. Balloon Catheters
5.2.3. Support Devices
5.2.3.1. Microcatheters
5.2.3.2. Guidewires
5.2.4. Neurothrombectomy devices
5.2.4.1. Clot Retrievals
5.2.4.2. Suction & Aspiration Devices
5.2.4.3. Snares
Chapter 6. Neurovascular Devices/Interventional Neurology Market Segmentation 2: By End-Users Estimates & Trend Analysis
6.1. By End-Users Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
6.2.1. Hospitals & surgical centers
6.2.2. Ambulatory care centers
6.2.3. Research laboratories & academic institutes
Chapter 7. Neurovascular Devices/Interventional Neurology Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2021-2034
7.1.2. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2021-2034
7.1.3. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034
7.2.2. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2021-2034
7.2.3. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034
7.3.2. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2021-2034
7.3.3. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034
7.4.2. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
7.4.3. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034
7.5.2. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
7.5.3. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Johnson & Johnson (US)
8.2.2. Medtronic PLC (Ireland)
8.2.3. Stryker Corporation (US)
8.2.4. Terumo Corporation (Japan)
8.2.5. Penumbra, Inc. (US)
8.2.6. Microport Scientific Corporation (China)
8.2.7. Kaneka Corp. (Japan)
8.2.8. Integer Holdings Corporation
8.2.9. Balt (France)
8.2.10. Perflow Medical
8.2.11. Phenox GmbH (Germany)
8.2.12. Sensome (France)
8.2.13. Evasc (Canada)
8.2.14. Rapid Medical (Israel)
8.2.15. Asahi Intecc Co. Ltd (Japan)
8.2.16. Acandis GmbH (Germany)
8.2.17. Medikit Co. Ltd (Japan)
8.2.18. Imperative Care (US)
8.2.19. Lepu Medical (China)
8.2.20. Cerus Endovascular (US)
8.2.21. MicroVention, Inc.
8.2.22. Mizuho Medical
8.2.23. Peter Lazic GmBH
8.2.24. Spartan Micro
8.2.25. Emboflu
8.2.26. Straub Medical AG
8.2.27. AngioDynamics
8.2.28. Stryker Corporation
Global Neurovascular Devices or Interventional Neurology Market, by Products,
Global Neurovascular Devices or Interventional Neurology Market, by End-Users,
Global Neurovascular Devices or Interventional Neurology Market, by Region,
North America Neurovascular Devices or Interventional Neurology Market, by Country,
Europe Neurovascular Devices or Interventional Neurology Market, by Country,
Asia Pacific Neurovascular Devices or Interventional Neurology Market, by Country,
Latin America Neurovascular Devices or Interventional Neurology Market, by Country,
Middle East & Africa Neurovascular Devices or Interventional Neurology Market, by Country,
Competitive Landscape
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
